Exchange: NASDAQ·Updated 08:09 AM EDT
GOVX logo

GOVXGeovax Labs Inc

$1.29
$0.02
(1.57%)
Pre-Market
Prev Close $1.27
Reported EarningsNov 13
Mkt Cap$6.62M
Vol2,616.00

About

GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. It focuses on preventive vaccines against hemorrhagic fever viruses such as Ebola-Zaire, Ebola-Sudan, Lassa, Marburg, Zika virus and malaria. The company was founded in June 1988 and is headquartered in Smyrna, GA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
19

Frequently Asked Questions

What is Market Cap of Geovax Labs Inc?
What is the 52-week high for Geovax Labs Inc?
What is the 52-week low for Geovax Labs Inc?
What is Geovax Labs Inc stock price today?
What was Geovax Labs Inc stock price yesterday?
What is the PE ratio of Geovax Labs Inc?
What is the Price-to-Book ratio of Geovax Labs Inc?
What is the 50-day moving average of Geovax Labs Inc?
How many employees does Geovax Labs Inc have?

Advertisement|Remove ads.